Abstract: Managing a battery including measuring, in response to a first charging current and over a first time period, a first amperage and a first voltage of the cell at predetermined intervals; measuring, in response to a second charging current and over a second time period, a second amperage and a second voltage of the cell at the predetermined intervals; determining that the first amperage of the cell was maintained greater than a first threshold amount of time within the first time period, and in response, qualifying the first amperage and the first voltage as stable; determining that the second amperage of the cell was maintained greater than a second threshold amount of time within the second time period, and in response, qualifying the second amperage and the second voltage as stable; and in response to the qualifying, calculating a DCIR of the cell based on the voltages and the amperage.

Abstract: Calibrating a battery including identifying a historical discharge rate of the battery; segmenting the historical discharge rate of the battery into regions; determining, based on the historical discharge rate of the battery, a first historical charge capacity of the battery for a first region and a second historical charge capacity of the battery for a second region; discharging, at an updated discharge rate, the battery from a first threshold voltage to a second threshold voltage; calculating, based on the updated discharge rate, a first updated charge capacity of the battery for the first region; determining a full charge capacity of the battery based on i) the first updated charge capacity of the battery for the first region and ii) the second historical charge capacity of the battery for the second region; adjusting a charging current of the battery based on the determined full charge capacity of the battery.

Abstract: Managing a battery including measuring, in response to a first charging current and over a first time period, a first amperage and a first voltage of the cell at predetermined intervals; measuring, in response to a second charging current and over a second time period, a second amperage and a second voltage of the cell at the predetermined intervals; determining that the first amperage of the cell was maintained greater than a first threshold amount of time within the first time period, and in response, qualifying the first amperage and the first voltage as stable; determining that the second amperage of the cell was maintained greater than a second threshold amount of time within the second time period, and in response, qualifying the second amperage and the second voltage as stable; and in response to the qualifying, calculating a DCIR of the cell based on the voltages and the amperage.

Abstract: Calibrating a battery including identifying a historical discharge rate of the battery; segmenting the historical discharge rate of the battery into regions; determining, based on the historical discharge rate of the battery, a first historical charge capacity of the battery for a first region and a second historical charge capacity of the battery for a second region; discharging, at an updated discharge rate, the battery from a first threshold voltage to a second threshold voltage; calculating, based on the updated discharge rate, a first updated charge capacity of the battery for the first region; determining a full charge capacity of the battery based on i) the first updated charge capacity of the battery for the first region and ii) the second historical charge capacity of the battery for the second region; adjusting a charging current of the battery based on the determined full charge capacity of the battery.

Abstract: A drug scanning and identification system including a spectrometer, a drug holder, a mobile device and a drug identification model is provided. The spectrometer includes a light source, a diffraction grating, a light-absorption element, a wavelength selector, and a single-point photodetector. The drug holder includes a transparent area and a light-absorption area. The drug is disposed on the transparent area. The light-absorption area surrounds the transparent area. The mobile device is adapted to send a control command to trigger the spectrometer scanning the drug so as to obtain spectrum data of the drug. The spectrometer is adapted to transmit the spectrum data of the drug to the drug identification model. The drug identification model is adapted to identify the spectrum data of the drug such that the drug identification model generates an identification result. The identification result is displayed by the mobile device.

Abstract: A drug scanning and identification system including a spectrometer, a drug holder, a mobile device and a drug identification model is provided. The spectrometer includes a light source, a diffraction grating, a light-absorption element, a wavelength selector, and a single-point photodetector. The drug holder includes a transparent area and a light-absorption area. The drug is disposed on the transparent area. The light-absorption area surrounds the transparent area. The mobile device is adapted to send a control command to trigger the spectrometer scanning the drug so as to obtain spectrum data of the drug. The spectrometer is adapted to transmit the spectrum data of the drug to the drug identification model. The drug identification model is adapted to identify the spectrum data of the drug such that the drug identification model generates an identification result. The identification result is displayed by the mobile device.

Abstract: In one or more embodiments, one or more systems, one or more methods, and/or one or more processes may determine multiple voltage values associated with a rechargeable battery over a period of time; store the multiple voltage values with respect to multiple clock values over the period of time; determine a voltage drop rate from the multiple voltage values and the multiple clock values; determine a threshold voltage value associated with a predicted energy capacity of the rechargeable battery for a mobile information handling system (IHS) to perform a power state transition; determine a voltage value associated with the rechargeable battery; determine that the voltage value has reached the threshold voltage value; provide a notification to an operating system executed by the mobile IHS; store data from a volatile memory medium to a non-volatile memory medium; and transition the mobile IHS from an operational state to a power conservation state.

Abstract: The present disclosure includes a PINK1-C-terminal domain (PINK1-CTD) polypeptide that binds to ERBB tyrosine kinase domain (ERBB-TKD) and therefore impedes ERBB from dimerization and activation. The PINK1-CTD polypeptide inhibits, prevents and/or treats ERBB-expressing cancers. The disclosure demonstrates the anti-tumor function of the PINK1-CTD, which provides a new direction for ERBB-expressing cancer therapy.

Abstract: A diagnostic system includes: a processor, arranged to extract a plurality of coordinates of a plurality of pins on an outer surface of a design layout according to a plurality of tagging texts labeling the plurality of pins respectively, and arranged to generate a design exchange format file according to the plurality of coordinates, wherein an order of the plurality of tagging texts are sorted by a predetermined scanning sequence; and a chip diagnostic tool, arranged to scan the plurality of scan components in a physical circuit on a testing platform through the plurality of pins on the outer surface of the physical circuit by following the predetermined scanning sequence to determine a defect component in the physical circuit according to the design exchange format file; wherein the physical circuit corresponds to the design layout.

Abstract: The present invention is related to an adjustable desk, which includes a long desktop, a slide rail mounted on the bottom surface of the desktop along the length direction thereof, and a sliding member slidably arranged in the slide rail, which comprises a connector connected with the sliding member, and a replaceable and detachable office furniture unit, such as keyboard holder, drawer cabinet, and etc., connected with the connector of the sliding member. In this way, when the user changes his/her seating position or use of the desk, the sliding members allow the office furniture units, such as the keyboard holder, the drawer cabinet, and etc., to be moved along the slide rails along the length direction of the desktop or replaced, so as for flexibly adjusting the keyboard holder and drawer cabinet to the user's new seating position in order to allow the user to operate the keyboard or to reach the drawer cabinet without being limited in a certain location at the desk for work.

Abstract: A fluorescent probe is obtained via hydrolysis and condensation reaction using 3-glycidoxypropyl trimethoxysilane. The fluorescent probe includes a silicon oxide core and a self-assembled monolayer. The self-assembled monolayer has an epoxide group, and joins the silicone oxide core by a covalent bond. The epoxide group of the fluorescent probe can form a conjugated bond with a molecule with an amino group via an aminolysis reaction, forming a nanoparticle including the molecule and the fluorescent probe.

Abstract: A diagnostic system includes: a processor, arranged to extract a plurality of coordinates of a plurality of pins on an outer surface of a design layout according to a plurality of tagging texts labeling the plurality of pins respectively, and arranged to generate a design exchange format file according to the plurality of coordinates, wherein an order of the plurality of tagging texts are sorted by a predetermined scanning sequence; and a chip diagnostic tool, arranged to scan the plurality of scan components in a physical circuit on a testing platform through the plurality of pins on the outer surface of the physical circuit by following the predetermined scanning sequence to determine a defect component in the physical circuit according to the design exchange format file; wherein the physical circuit corresponds to the design layout.

Abstract: A diagnostic system includes a location extractor, a file generator, and a chip diagnostic tool. The location extractor is arranged to extract at least a coordinate of at least one component in an intellectual property design layout of an integrated circuit design layout according to at least one tagging text labeling the at least one component in the intellectual property design layout. The file generator is arranged to generate a format file according to the at least coordinate. The chip diagnostic tool is arranged to scan a physical intellectual property circuit in a physical integrated circuit to determine a defect component in the physical intellectual property circuit according to the format file. The physical intellectual property circuit corresponds to the intellectual property design layout, and the physical integrated circuit corresponds to the integrated circuit design layout.

Abstract: A nanodot for detecting glucose concentration includes a silicon oxide core, a self-assembled monolayer having a 3-glycidoxypropyl trimethoxysilane group, and a glucose oxidase particle. The self-assembled monolayer joins the silicon oxide core by a covalent bond, and the glucose oxidase particle joins the 3-glycidoxypropyl trimethoxysilane group of the self-assembled monolayer by a conjugated bond. Moreover, a method for detecting glucose concentration by the nanodot includes oxidizing a glucose molecule in a glucose solution by the glucose oxidase particle of the nanodot, producing a hydrogen peroxide molecule; fluorescent quenching the nanodot by the hydrogen peroxide molecule, resulting in a change in fluorescent intensity of the nanodot; and detecting the change in fluorescent intensity of the nanodot.

Abstract: The present disclosure includes a PINK1-C-terminal domain (PINK1-CTD) polypeptide that binds to ERBB tyrosine kinase domain (ERBB-TKD) and therefore impedes ERBB from dimerization and activation. The PINK1-CTD polypeptide inhibits, prevents and/or treats ERBB-expressing cancers. The disclosure demonstrates the anti-tumor function of the PINK1-CTD, which provides a new direction for ERBB-expressing cancer therapy.

Abstract: A diagnostic system includes a location extractor, a file generator, and a chip diagnostic tool. The location extractor is arranged to extract at least a coordinate of at least one component in an intellectual property design layout of an integrated circuit design layout according to at least one tagging text labeling the at least one component in the intellectual property design layout. The file generator is arranged to generate a format file according to the at least coordinate. The chip diagnostic tool is arranged to scan a physical intellectual property circuit in a physical integrated circuit to determine a defect component in the physical intellectual property circuit according to the format file. The physical intellectual property circuit corresponds to the intellectual property design layout, and the physical integrated circuit corresponds to the integrated circuit design layout.

Abstract: The present invention provides a composition for alleviating and preventing Alzheimer's disease. This composition comprises at least one yellow pigment extracted from a red mold product, and the said yellow pigment is Monascin or Ankaflavin. Moreover, after completing a variety of experiments, the composition has been proved possessing effects on alleviating and preventing AD by alleviating the symptoms of memory loss and learning disability resulted from the ?-amyloid accumulated in brain of rats as well as reducing the inflammation and the oxidative stress caused by the ?-amyloid in cerebral cortex and hippocampus tissue. Therefore, the experimental results have proved that this novel composition is indeed able to treat and prevent Alzheimer's disease.

Abstract: The present disclosure provides a method for manufacturing a nanodot, including: providing a hydrolysable silane, wherein the hydrolysable silane has one or more hydrolysable groups and one or more substituted or non-substituted hydrocarbon groups; and performing a one-step heat treatment to hydrolyze and condensate the hydrolysable silane to form a nanodot. The nanodot includes: a core, the core is selected from the group consisting of a semiconductor core or a metal core; and a self-assembled monolayer (SAM) including the substituted or non-substituted hydrocarbon groups, wherein the self-assembled monolayer is connected to the core by covalent bonds.

Abstract: The present disclosure provides a method for manufacturing a nanodot, including: providing a hydrolysable silane, wherein the hydrolysable silane has one or more hydrolysable groups and one or more substituted or non-substituted hydrocarbon groups; and performing a one-step heat treatment to hydrolyze and condensate the hydrolysable silane to form a nanodot. The nanodot includes: a core, the core is selected from the group consisting of a semiconductor core or a metal core; and a self-assembled monolayer (SAM) including the substituted or non-substituted hydrocarbon groups, wherein the self-assembled monolayer is connected to the core by covalent bonds.

Abstract: A die includes a plurality of through-substrate vias (TSVs) penetrating a substrate of the die, wherein the plurality of TSVs are grouped as a plurality of TSV pairs. A plurality of contact pads is coupled to the plurality of TSVs, wherein the plurality of contact pads is exposed on a first surface of the die. The die further includes a plurality of balanced pulse comparison units, wherein each of the plurality of balanced pulse comparison units includes a first input and a second input coupled to a first TSV and a second TSV of one of the plurality of TSV pairs. The die further includes a plurality of pulse latches, each including an input coupled to an output of one of the plurality of balanced pulse comparison units.